Lentigo maligna is melanoma in situ, or Stage 0 melanoma, that usually develops slowly on chronically sun-damaged skin of the face, scalp or neck. It often begins as a flat irregular pigmented patch that gradually enlarges and becomes more asymmetric, unevenly bordered or varied in colour, particularly in older sun-damaged skin.
The H1 wording “precancerous skin patch” is incomplete: lentigo maligna is already melanoma in situ because malignant melanocytes are present within the epidermis. While the disease remains fully in situ it lacks direct metastatic potential, but if malignant cells enter the dermis the diagnosis becomes lentigo maligna melanoma and the management pathway changes.
A new or enlarging irregular pigmented lesion should receive prompt professional assessment, especially if it develops black, grey, blue or pink areas, a new raised component, a nodule, bleeding, ulceration, crusting or rapid focal change. Seek earlier review when a previously flat patch develops focal thickening or looks distinctly different from nearby spots. Do not bleach, freeze, scrape or laser-treat an undiagnosed suspicious pigmented lesion, because cosmetic destruction can delay histologic diagnosis and obscure clinically important change.
How Can You Recognize Lentigo Maligna?
Lentigo maligna usually appears as a slowly enlarging, flat, irregularly pigmented patch on chronically sun-damaged skin, especially the face.
What Does Lentigo Maligna Usually Look Like?
Lentigo maligna usually appears as a flat, irregularly shaped pigmented patch that gradually becomes more asymmetric, unevenly bordered and varied in colour.
Pigmentation can include light brown, dark brown, black, grey, pink and occasional white areas. Edges can become poorly defined and the shape progressively asymmetric. Early lentigo maligna can closely resemble an ordinary age spot, and not every lesion shows dramatic colour variation at first.
Where Does Lentigo Maligna Usually Develop?
Lentigo maligna most often develops on chronically sun-damaged areas of the head and neck, particularly the face.
Common sites include the cheeks, nose, temples, forehead, ears, scalp and neck. Facial lentigo maligna can develop among numerous ordinary solar lentigines, which can make visual recognition more difficult.
How Quickly Does Lentigo Maligna Grow?
Lentigo maligna often enlarges slowly outward over several years rather than changing dramatically over a few weeks.
The malignant melanocytes expand radially within the epidermis. Apparent month-to-month stability can therefore be misleading because the clinically important pattern may be gradual enlargement across years rather than sudden rapid change.
Which Changes Suggest Possible Invasion?
A new raised, nodular, thickened, ulcerated, bleeding or rapidly changing area within lentigo maligna raises concern for invasive lentigo maligna melanoma.
- New papule or nodule.
- Focal thickening.
- Ulceration.
- Bleeding.
- Repeated crusting.
- Rapid local growth.
- New black, blue or distinctly different-coloured focus.
A new vertical or raised change matters because invasion means malignant melanocytes may have entered the dermis.
Figure 1. Lentigo maligna usually enlarges slowly within the epidermis. A new raised, thickened, nodular, ulcerated or bleeding focus raises concern that malignant melanocytes may have entered the dermis.
Why Does Lentigo Maligna Develop, and What Makes It Dangerous?
Lentigo maligna develops mainly from cumulative ultraviolet damage to melanocytes and becomes dangerous when malignant cells invade from the epidermis into the dermis.
How Does Long-Term Sun Exposure Contribute to Lentigo Maligna?
Long-term ultraviolet exposure contributes to lentigo maligna by creating accumulated DNA damage in melanocytes within chronically sun-damaged skin.
Decades of repeated UV exposure create cumulative DNA injury rather than one isolated recent sunburn. Malignant melanocytes then expand along the epidermis and adnexal structures within the chronically photodamaged field.
Who Is More Likely to Develop Lentigo Maligna?
Lentigo maligna occurs most often in older adults with substantial cumulative sun damage, particularly on chronically exposed facial skin.
- Older age.
- Long-term outdoor or occupational sun exposure.
- Extensive actinic damage.
- Fair skin as a frequent clinical context.
- Previous keratinocyte skin cancer.
These factors increase risk but do not diagnose lentigo maligna; any atypical or changing lesion deserves assessment regardless of age or skin tone.
Is Lentigo Maligna Already Skin Cancer?
Yes; lentigo maligna is melanoma in situ, meaning malignant melanocytes are present but remain confined to the epidermis.
Lentigo maligna is Stage 0 melanoma. Calling it merely precancerous understates the diagnosis because the cells are already malignant, although they have not yet entered the dermis and pure in-situ disease lacks direct metastatic potential.
How Does Lentigo Maligna Become Lentigo Maligna Melanoma?
Lentigo maligna becomes lentigo maligna melanoma when malignant melanocytes cross the epidermal boundary and invade the dermis.
Dermal invasion creates access to deeper tissue and introduces metastatic potential. Breslow thickness becomes clinically relevant only after invasion is identified, and the treatment plan then follows invasive melanoma principles.
Can Doctors Predict Which Lentigo Maligna Will Become Invasive?
No; clinicians cannot reliably predict whether or when an individual lentigo maligna will develop an invasive focus.
Some lesions remain in situ for years, while others contain or later develop an invasive component. Large, longstanding or changing lesions therefore need careful sampling because a small invasive focus can exist within a broad flat patch.
Figure 2. Lentigo maligna contains malignant melanocytes confined to the epidermis. Once an invasive focus crosses into the dermis, the diagnosis becomes lentigo maligna melanoma and invasive-melanoma staging becomes relevant.
How Is Lentigo Maligna Distinguished and Diagnosed?
Lentigo maligna is distinguished from benign pigmented lesions through clinical examination and dermoscopy, but definitive diagnosis requires histopathologic examination of a biopsy.
How Is Lentigo Maligna Different From an Ordinary Solar Lentigo?
A solar lentigo is benign and usually remains relatively uniform, whereas lentigo maligna becomes more suspicious through progressive enlargement, asymmetry, irregular borders and colour variation.
Early LM can closely mimic a solar lentigo / sunspot, especially on a face with extensive photodamage, so morphology alone can be insufficient.
Which Other Lesions Can Resemble Lentigo Maligna?
Seborrhoeic keratosis, pigmented actinic keratosis, melanocytic naevi and other pigmented melanoma patterns can resemble lentigo maligna.
A seborrhoeic keratosis may be pigmented and irregular but often develops a thicker or waxier surface.
A pigmented actinic keratosis can occur on the same sun-damaged facial field and may introduce rough or scaly keratinocytic features.
A melanocytic nevus / mole can also overlap visually, which is why lesion history and dermoscopic structure matter.
How Does Dermoscopy Help Diagnose Lentigo Maligna?
Dermoscopy helps identify suspicious pigment structures within lentigo maligna and can guide which part of a broad lesion should be biopsied.
A dermatoscope magnifies and illuminates pigment and follicular structures that are less reliable to judge with the naked eye. Dermoscopy can help choose a biopsy target but does not replace histopathology.
Why Is a Skin Biopsy Necessary for Lentigo Maligna?
A skin biopsy is necessary because lentigo maligna can only be definitively confirmed by identifying melanoma cells histologically within tissue.
Histopathology establishes malignant melanocytes confined to the epidermis and looks for any invasive focus. Surface appearance alone cannot provide the definitive melanoma diagnosis.
How Is a Large Lentigo Maligna Sampled?
Large lentigo maligna lesions may require strategically targeted biopsies from the most suspicious areas when complete initial excision is impractical.
Incisional or punch biopsies can target raised, darker, ulcerated or dermoscopically different areas. Because a partial biopsy samples only part of a broad lesion, sampling error can miss an invasive focus elsewhere.
Can the Diagnosis Change After Complete Removal?
Yes; a lesion initially diagnosed as lentigo maligna can be upstaged to invasive melanoma if complete excision reveals a previously unsampled invasive focus.
A larger complete specimen reveals more of the lesion than one partial biopsy. If invasion is found, the diagnosis and treatment pathway change to invasive melanoma.
Can Advanced Imaging Help Define Lentigo Maligna Margins?
Reflectance confocal microscopy can help map the lateral extent of selected poorly defined lentigo maligna lesions in specialist centres, but it does not replace histologic confirmation.
It is most relevant to large or indistinct facial lesions when expertise and equipment are available. It functions as an adjunct for mapping rather than a universal requirement.
| Lesion | Typical Behaviour | Surface / Colour Clue | Major Safety Difference |
|---|---|---|---|
| Lentigo maligna | Slowly enlarging over years | Flat, irregular pigment with evolving asymmetry | Stage 0 melanoma; biopsy required. |
| Solar lentigo | Usually stable and persistent | Relatively uniform flat brown macule | Benign lesion. |
| Seborrhoeic keratosis | Persistent | Often thicker, waxy or stuck-on | Benign keratinocytic growth. |
| Pigmented actinic keratosis | Persistent on photodamaged skin | Rough or scaly with possible pigment | Precancerous keratinocytic lesion. |
| Melanocytic nevus | Usually stable | Flat or raised melanocytic lesion | Can overlap visually; atypical change needs assessment. |
Figure 3. Dermoscopy helps identify suspicious structures and biopsy targets, but histopathology confirms lentigo maligna. Large lesions may require strategic sampling and margin mapping because a small invasive focus can be missed by one partial biopsy.
How Is Lentigo Maligna Treated?
Lentigo maligna is treated primarily with complete surgical removal that achieves histologic clearance while preserving as much uninvolved tissue as practical.
Why Is Surgical Removal the Preferred Treatment for Lentigo Maligna?
Surgical removal is preferred because it both removes lentigo maligna and provides tissue for microscopic assessment of margins and unexpected invasion.
The treatment goal is microscopic clearance, not merely disappearance of visible pigmentation. A complete specimen also improves the chance of detecting an invasive focus that was not captured by the initial biopsy.
How Much Normal Skin Is Removed Around Lentigo Maligna?
Melanoma-in-situ surgery commonly begins with a clinical margin of at least 5 mm, but lentigo maligna may require wider clearance because microscopic extension can exceed the visible border.
Five millimetres is a starting guideline concept rather than a universal guarantee of clearance. Facial photodamage and subclinical extension mean the treating team may individualize the margin or use margin-controlled techniques.
When Are Staged Excision or Mohs-Type Techniques Useful?
Staged excision or Mohs-type margin-controlled surgery is especially useful for lentigo maligna in tissue-sensitive facial sites where precise margin assessment and tissue preservation matter.
The approach can be useful on the face, nose, eyelid, ear and other anatomically constrained sites. It allows detailed peripheral margin assessment while conserving uninvolved tissue; not every lentigo maligna requires Mohs-type surgery.
When Can Imiquimod Be Used for Lentigo Maligna?
Topical imiquimod may be considered off-label for selected lentigo maligna when surgery is impractical, contraindicated or declined.
Imiquimod is a nonsurgical alternative rather than an equivalent substitute for surgery. It does not provide a complete surgical specimen, residual disease can remain, and recurrence or unrecognized invasion remains a concern.
When Is Radiation Therapy Considered for Lentigo Maligna?
Radiotherapy can be considered for selected lentigo maligna patients who cannot undergo surgery or for whom surgery would create unacceptable morbidity.
Radiotherapy is a specialist-selected alternative rather than routine first-line treatment for ordinary operable disease.
Why Aren’t Freezing or Cosmetic Lasers Standard Treatment for Lentigo Maligna?
Cryotherapy and cosmetic lasers are not standard lentigo maligna treatments because destroying visible pigment does not confirm complete removal of malignant melanocytes or histologic margins.
Pigment may disappear while malignant cells remain, and cosmetic destruction provides no complete margin assessment. It can also complicate diagnosis if an invasive focus was never sampled.
What Changes if Invasive Lentigo Maligna Melanoma Is Found?
If dermal invasion is found, management changes from Stage 0 lentigo maligna treatment to the invasive melanoma pathway.
Breslow thickness and other invasive characteristics guide wider excision and any additional staging. Lymph-node assessment is considered only when clinically appropriate for invasive melanoma, not as a routine step for pure melanoma in situ.
| Finding / Situation | Treatment Direction |
|---|---|
| Confirmed operable lentigo maligna | Complete surgical clearance with histologic margin assessment. |
| Facial or anatomically constrained lentigo maligna | Consider staged excision or Mohs-type margin control when appropriate. |
| Surgery impractical or contraindicated | Selected nonsurgical therapy such as imiquimod or radiotherapy may be considered by specialists. |
| Visible pigment removed without histology | Does not establish oncologic clearance. |
| Invasive focus discovered | Switch to invasive melanoma staging and treatment based on invasive characteristics. |
| After clear margins | Monitor treatment site and perform ongoing full-skin surveillance. |
What Happens After Lentigo Maligna Treatment?
After lentigo maligna treatment, follow-up focuses on local recurrence, new melanoma detection and continued surveillance of chronically sun-damaged skin.
Can Lentigo Maligna Come Back?
Yes; lentigo maligna can recur locally if microscopic disease remains beyond the treated margin.
Subclinical extension makes histologic margin clearance important. New pigmentation within or beside a scar deserves review, although pigmentation in a scar is not automatically recurrent melanoma.
What Is the Outlook After Complete Treatment?
The outlook is excellent when lentigo maligna remains fully in situ and is completely removed because epidermis-confined melanoma lacks direct metastatic potential.
The prognosis changes when dermal invasion is identified because the disease then follows an invasive melanoma pathway rather than a Stage 0 pathway.
Why Is Ongoing Full-Skin Examination Important After Lentigo Maligna?
Full-skin surveillance is important because a person with melanoma in situ has an increased risk of developing another primary melanoma.
Follow-up reviews the original treatment site and the rest of the skin. Frequency is individualized according to melanoma history, skin findings, recurrence risk and the person’s overall risk profile.
How Can Additional UV Damage Be Reduced After Lentigo Maligna?
Long-term photoprotection reduces further ultraviolet damage to the surrounding chronically sun-damaged skin after lentigo maligna treatment.
- Limit intense UV exposure.
- Avoid tanning beds.
- Seek shade.
- Wear protective clothing.
- Protect the scalp with an appropriate hat.
- Protect the face, neck and hands consistently.
Photoprotection limits additional damage but does not reverse the previous melanoma-in-situ diagnosis.
Which Changes Should Trigger Earlier Review After Lentigo Maligna Treatment?
New pigmentation, asymmetry, colour change, enlargement, bleeding, crusting or a new raised focus within or near the treated area should prompt earlier reassessment.
A new suspicious lesion elsewhere also deserves review. Slow evolution still matters, so lack of rapid growth is not sufficient reassurance.
What Should You Remember About Lentigo Maligna?
Lentigo maligna is Stage 0 melanoma that remains confined to the epidermis but requires complete treatment because it can develop an invasive focus.
- Lentigo maligna is melanoma in situ, not a benign or merely precancerous sunspot.
- It usually develops slowly on chronically sun-damaged facial skin.
- Early lentigo maligna can resemble an ordinary solar lentigo.
- A new nodular, thickened, bleeding or ulcerated focus raises concern for invasion.
- Biopsy and histopathology are required for diagnosis.
- Large lesions may contain an invasive focus missed by one partial biopsy.
- Complete surgical removal with microscopic margin assessment is preferred for most operable disease.
- Margin-controlled surgery can help on selected difficult facial sites.
- Imiquimod and radiotherapy are selected alternatives when surgery is unsuitable.
- Recurrence and additional primary melanoma make long-term surveillance important.
The clinical pathway is recognize → biopsy → check for invasion → map extent → clear margins → monitor.
Frequently Asked Questions About Lentigo Maligna?
The most important lentigo maligna questions concern its melanoma classification, invasive risk, diagnosis, treatment and recurrence.
Is Lentigo Maligna Actually Melanoma?
Yes; lentigo maligna is melanoma in situ, also called Stage 0 melanoma. Malignant melanocytes are already present but remain confined to the epidermis. The diagnosis changes to lentigo maligna melanoma only when malignant cells invade into the dermis.
How Can Lentigo Maligna Be Distinguished From an Ordinary Sunspot?
Lentigo maligna becomes more suspicious than an ordinary sunspot when it progressively enlarges, becomes asymmetric or develops irregular borders and multiple colours. Early lentigo maligna can still resemble a benign solar lentigo, so dermoscopy and biopsy may be required.
Can Lentigo Maligna Become Invasive Melanoma?
Yes; lentigo maligna becomes lentigo maligna melanoma when malignant melanocytes invade from the epidermis into the dermis. Invasion creates metastatic potential and introduces Breslow thickness and other invasive-melanoma features into treatment and staging decisions.
What Is the Preferred Treatment for Lentigo Maligna?
Complete surgical removal with histologic margin assessment is the preferred treatment for most operable lentigo maligna. Staged excision or Mohs-type techniques can be useful on facial or anatomically constrained sites where microscopic margin control and tissue preservation are important.
Can Lentigo Maligna Return After Treatment?
Yes; lentigo maligna can recur locally, especially if microscopic extensions remain beyond the treated margins. Follow-up therefore includes review of the treatment site and surrounding scar as well as full-skin surveillance for additional primary melanoma.
Which Sources Support This Lentigo Maligna Guidance?
DermNet — Lentigo Maligna and Lentigo Maligna Melanoma — Clinical morphology, head-and-neck distribution, slow radial growth, chronic sun damage, warning signs of invasion, dermal transition, surgery and recurrence context.
DermNet — Melanoma in Situ — Stage 0 classification, epidermal confinement, in-situ versus invasive distinction, biopsy confirmation, differential diagnosis and prognosis.
American Academy of Dermatology — Melanoma Diagnosis and Treatment — Melanoma staging framework, surgical treatment and the clinical pathway after invasive disease is identified.
American Academy of Dermatology — Melanoma Clinical Guideline — Biopsy principles, surgery as treatment cornerstone, staged or Mohs-type margin assessment for lentigo maligna and limitations of nonsurgical therapy.
National Cancer Institute — Melanoma Treatment PDQ — Stage 0 excision, at-least-5-mm starting margin concept and the goal of microscopically negative margins.
PubMed — Evidence-Based Clinical Practice Guidelines for Lentigo Maligna — Reflectance confocal microscopy, surgical and nonsurgical treatment hierarchy, radiotherapy and the recommendation against cosmetic laser or cryotherapy as LM treatment.
